Laurence M. Corash - Mar 1, 2024 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Jensen, attorney-in-fact
Stock symbol
CERS
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 06:16 PM
Previous filing
Mar 14, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Restricted Stock Unit Award $0 +90K +3.98% $0.00 2.35M Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.